EGFR and neoplasm: Oncogenic alterations in EGFR are frequently reported in patients with lung cancer and are implicated in the pathogenesis of the disease such as increased tumor proliferation, poor differentiation, and a worse prognosis, indicating that EGFR is an important therapeutic target in lung cancer [4-7].